EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Angiogenetic Factors in Hepatocellular Carcinoma During Transarterial Chemoembolization: A Pilot Study

Joško Osredkar iD, Špela Koršič iD, Uršula Prosenc Zmrzljak iD, Hana Trček, Peter Popović

Cancers · 13.08.2025 · 17 (16) · 2642

DOI: 10.3390/cancers17162642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 13.08.2025. Verfasst von Joško Osredkar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Centre Ljubljana, Slovenian Research and Innovation Agency (ARIS) program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and remains a significant global health challenge. Transarterial chemoembolization (TACE) is the treatment of choice for intermediate-stage HCC patients. While TACE induces localized cytotoxic and ischemic tumor necrosis, the resultant hypoxia paradoxically activates pro-angiogenic signaling pathways, which may promote tumor revascularization and recurrence. This study aimed to evaluate the plasma levels of angiogenetic factors pre- and post-TACE to assess their dynamic changes and potential clinical implications.

Methods

Twenty-five intermediate-stage HCC patients were included in this monocentric prospective study. Peripheral blood samples were collected at baseline (pre-TACE), 24 h, 3 days, and 1 month post-TACE. Angiogenic factor levels were analyzed using a multiplex bead-based assay.

Results

Angiopoietin-2 levels were significantly elevated three days post-TACE, followed by a gradual decline after one month. A similar pattern was observed for hepatocyte growth factor, with a marked increase at 24 h post-TACE and subsequent normalization. Endothelin-1 also exhibited a temporary increase, although it was only detected in four patients. Fibroblast growth factors (1 and 2) and vascular endothelial growth factor A were detected in a limited number of patients, which may indicate low systemic release or the need for a more sensitive detection method.

Conclusions

These findings suggest that TACE induces a transient increase in angiogenic factors, likely due to tumor ischemia, tissue injury, or microenvironmental responses. Future studies should explore more sensitive detection methods and evaluate whether these factors could serve as prognostic biomarkers or therapeutic targets in HCC treatment.

Schlagwörter

Stichwörter der Autor:innen

FGF-1FGF-2HGFVEGF-Aangiogenesisangiopoietin-2endothelin-1hepatocellular carcinomatransarterial chemoembolization

Autor:innen und Institutionen

  • Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.
  • Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.
  • Clinical Institute of Radiology, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.
  • Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
  • Molecular Biology Laboratory, BIA Separations CRO, Labena Ltd., 1000 Ljubljana, Slovenia.
  • Centre for Functional Genomics and Bio-Chips, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Zaloška Cesta 4, 1000 Ljubljana, Slovenia.

ORCID-Profile: Joško Osredkar, Špela Koršič, Uršula Prosenc Zmrzljak

Förderung

  • University Medical Centre Ljubljana
  • Slovenian Research and Innovation Agency (ARIS) program

Zitieren

APA

Osredkar, J., Koršič, Š., Prosenc Zmrzljak, U., Trček, H., & Popović, P. (2025). Angiogenetic Factors in Hepatocellular Carcinoma During Transarterial Chemoembolization: A Pilot Study. Cancers, 17(16), 2642. https://doi.org/10.3390/cancers17162642

Vancouver

Osredkar J, Koršič Š, Prosenc Zmrzljak U, Trček H, Popović P. Angiogenetic Factors in Hepatocellular Carcinoma During Transarterial Chemoembolization: A Pilot Study. Cancers. 2025;17(16):2642. doi:10.3390/cancers17162642

BibTeX
@article{Osredkar2025,
  author = {Osredkar, Joško and Koršič, Špela and Prosenc Zmrzljak, Uršula and Trček, Hana and Popović, Peter},
  title = {Angiogenetic Factors in Hepatocellular Carcinoma During Transarterial Chemoembolization: A Pilot Study},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {16},
  pages = {2642},
  doi = {10.3390/cancers17162642}
}
Kostenlos starten →